Nivolumab combined with high dose multisite radiotherapy in previously untreated advanced melanoma (NIRVANA): A non-randomised, open-label, multicenter, phase 2 trial. This is an ASCO Meeting Abstract ...
Personalized Medicine. 2014;11(6):581-592. Both enrichment methods were able to efficiently enrich the overlapping target region. Estimated enrichment factors were in the mean 4400-fold (SD ± 1613) ...
SAN DIEGO--(BUSINESS WIRE)--Inocras, an industry leader in whole genome sequencing and bioinformatics, released a new study highlighting the clinical validation of its CancerVision Target-Enhanced ...
A cancer diagnosis is one of the most dreaded news an individual and their family could receive. In the past, many scientists and clinicians have searched for a definitive cure for cancer. However, ...
It's time for a genomics reality check. Despite the constant, glowing coverage of speedy, low-cost next-generation DNA sequencing, whole-genome analysis, and consumer genomics, researchers still have ...
Hosted on MSN
Wasatch Biolabs announces co-marketing agreement with Agilent to advance native-read targeted sequencing
Wasatch BioLabs (WBL), a leader in native, long-read sequencing and epigenomic analysis, today announced a co-marketing agreement with Agilent Technologies to support the adoption of its Direct ...
Precision Dx Products include Twist Precision Prep and Enrichment Dx Kit, Twist Precision Exome Dx Panel and Twist Precision Exome Dx Kit SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist ...
A whole-genome sequencing approach shows early promise over current commercial methods for identifying more patients likely ...
In a recent study published in Nature, a group of researchers provided a comprehensive genomic characterization of colorectal carcinoma (CRC), a type of cancer that starts in the colon or rectum, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback